Literature DB >> 28471108

DNA methylation in the tumor microenvironment.

Meng-Wen Zhang1,2,3,4, Kenji Fujiwara3,4, Xu Che3,4, Shu Zheng1,2, Lei Zheng3,4.   

Abstract

The tumor microenvironment (TME) plays an important role in supporting cancer progression. The TME is composed of tumor cells, the surrounding tumor-associated stromal cells, and the extracellular matrix (ECM). Crosstalk between the TME components contributes to tumorigenesis. Recently, one of our studies showed that pancreatic ductal adenocarcinoma (PDAC) cells can induce DNA methylation in cancer-associated fibroblasts (CAFs), thereby modifying tumor-stromal interactions in the TME, and subsequently creating a TME that supports tumor growth. Here we summarize recent studies about how DNA methylation affects tumorigenesis through regulating tumor-associated stromal components including fibroblasts and immune cells. We also discuss the potential for targeting DNA methylation for the treatment of cancers.

Entities:  

Keywords:  Tumor microenvironment (TME); DNA methylation; Cancer-associated fibroblasts; Cancer-associated immune cells; Epigenetic therapy

Mesh:

Substances:

Year:  2017        PMID: 28471108      PMCID: PMC5442975          DOI: 10.1631/jzus.B1600579

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  64 in total

1.  Global hypomethylation of genomic DNA in cancer-associated myofibroblasts.

Authors:  Le Jiang; Tamas A Gonda; Mary V Gamble; Martha Salas; Venkatraman Seshan; Shuiping Tu; William S Twaddell; Peter Hegyi; Gyorgy Lazar; Islay Steele; Andrea Varro; Timothy C Wang; Benjamin Tycko
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

2.  Genome-wide analysis of promoter methylation associated with gene expression profile in pancreatic adenocarcinoma.

Authors:  Audrey Vincent; Noriyuki Omura; Seung-Mo Hong; Andrew Jaffe; James Eshleman; Michael Goggins
Journal:  Clin Cancer Res       Date:  2011-05-24       Impact factor: 12.531

Review 3.  Pancreatic cancer stroma: understanding biology leads to new therapeutic strategies.

Authors:  Agnieszka Anna Rucki; Lei Zheng
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

Review 4.  Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue.

Authors:  George S Karagiannis; Theofilos Poutahidis; Susan E Erdman; Richard Kirsch; Robert H Riddell; Eleftherios P Diamandis
Journal:  Mol Cancer Res       Date:  2012-09-28       Impact factor: 5.852

Review 5.  Friends or foes - bipolar effects of the tumour stroma in cancer.

Authors:  Margareta M Mueller; Norbert E Fusenig
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

Review 6.  The effect of GH and IGF1 on linear growth and skeletal development and their modulation by SOCS proteins.

Authors:  S F Ahmed; C Farquharson
Journal:  J Endocrinol       Date:  2010-07-14       Impact factor: 4.286

Review 7.  Epigenetic changes in cancer.

Authors:  Kirsten Grønbaek; Christoffer Hother; Peter A Jones
Journal:  APMIS       Date:  2007-10       Impact factor: 3.205

8.  Epigenetic Changes during Hepatic Stellate Cell Activation.

Authors:  Silke Götze; Eva C Schumacher; Claus Kordes; Dieter Häussinger
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

9.  MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis.

Authors:  Jelena Mann; David C K Chu; Aidan Maxwell; Fiona Oakley; Nian-Ling Zhu; Hidekazu Tsukamoto; Derek A Mann
Journal:  Gastroenterology       Date:  2009-10-17       Impact factor: 22.682

10.  Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus.

Authors:  Jian-Feng Xiang; Qing-Fei Yin; Tian Chen; Yang Zhang; Xiao-Ou Zhang; Zheng Wu; Shaofeng Zhang; Hai-Bin Wang; Junhui Ge; Xuhua Lu; Li Yang; Ling-Ling Chen
Journal:  Cell Res       Date:  2014-03-25       Impact factor: 25.617

View more
  12 in total

1.  DNA Methyltransferases as Potential Biomarkers for HCV Related Hepatocellular Carcinoma.

Authors:  Mona M Hassouna; Mary Naguib; Enas M Radwan; Mohamed Abdel-Samiee; Suzanne Estaphan; Eman Abdelsameea
Journal:  Asian Pac J Cancer Prev       Date:  2020-11-01

Review 2.  The evolving landscape of N6-methyladenosine modification in the tumor microenvironment.

Authors:  Yunru Gu; Xi Wu; Jingxin Zhang; Yuan Fang; Yutian Pan; Yongqian Shu; Pei Ma
Journal:  Mol Ther       Date:  2021-04-09       Impact factor: 11.454

Review 3.  Teaming Up for Trouble: Cancer Cells, Transforming Growth Factor-β1 Signaling and the Epigenetic Corruption of Stromal Naïve Fibroblasts.

Authors:  Sergio Lamprecht; Ina Sigal-Batikoff; Shraga Shany; Naim Abu-Freha; Eduard Ling; George J Delinasios; Keren Moyal-Atias; John G Delinasios; Alexander Fich
Journal:  Cancers (Basel)       Date:  2018-02-27       Impact factor: 6.639

4.  Genome-wide analysis of the hypoxia-related DNA methylation-driven genes in lung adenocarcinoma progression.

Authors:  Hongxia Li; Li Tong; Hong Tao; Zhe Liu
Journal:  Biosci Rep       Date:  2020-02-28       Impact factor: 3.840

Review 5.  The DNA methylation landscape of hematological malignancies: an update.

Authors:  Pedro Blecua; Laura Martinez-Verbo; Manel Esteller
Journal:  Mol Oncol       Date:  2020-07-03       Impact factor: 6.603

6.  Identification of key methylation differentially expressed genes in posterior fossa ependymoma based on epigenomic and transcriptome analysis.

Authors:  Guanyi Wang; Yibin Jia; Yuqin Ye; Enming Kang; Huijun Chen; Jiayou Wang; Xiaosheng He
Journal:  J Transl Med       Date:  2021-04-26       Impact factor: 5.531

7.  SNHG3 Affects Gastric Cancer Development by Regulating SEPT9 Methylation.

Authors:  Wei Li; Xudong Ma; Feng Wang; Shi Chen; Qingxiong Guo; Feng Sun; Yongqing Duan
Journal:  J Oncol       Date:  2022-04-28       Impact factor: 4.501

8.  Gene Body Methylation of the Lymphocyte-Specific Gene CARD11 Results in Its Overexpression and Regulates Cancer mTOR Signaling.

Authors:  Michael H McGuire; Santosh K Dasari; Hui Yao; Yunfei Wen; Lingegowda S Mangala; Emine Bayraktar; Wencai Ma; Cristina Ivan; Einav Shoshan; Sherry Y Wu; Eric Jonasch; Menashe Bar-Eli; Jing Wang; Keith A Baggerly; Anil K Sood
Journal:  Mol Cancer Res       Date:  2021-08-04       Impact factor: 5.852

9.  The microRNA-15a-PAI-2 axis in cholangiocarcinoma-associated fibroblasts promotes migration of cancer cells.

Authors:  Penkhae Utaijaratrasmi; Kulthida Vaeteewoottacharn; Takaaki Tsunematsu; Pranisa Jamjantra; Sopit Wongkham; Chawalit Pairojkul; Narong Khuntikeo; Naozumi Ishimaru; Yongyut Sirivatanauksorn; Ananya Pongpaibul; Peti Thuwajit; Chanitra Thuwajit; Yasusei Kudo
Journal:  Mol Cancer       Date:  2018-01-18       Impact factor: 27.401

10.  A New Epigenetic Model to Stratify Glioma Patients According to Their Immunosuppressive State.

Authors:  Maurizio Polano; Emanuele Fabbiani; Eva Adreuzzi; Federica Di Cintio; Luca Bedon; Davide Gentilini; Maurizio Mongiat; Tamara Ius; Mauro Arcicasa; Miran Skrap; Michele Dal Bo; Giuseppe Toffoli
Journal:  Cells       Date:  2021-03-05       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.